We present extensive optical (UBVRI), near-infrared (JK) light curves and optical spectroscopy
of the Type Ia supernova SN 2006X in the nearby galaxy NGC 4321 (M100). Our …

Small cell lung cancer (SCLC) is an aggressive disease with poor survival. A few sequencing
studies performed on limited number of samples have revealed potential disease-driving …

To explore the optimal treatment strategy for patients who harbor sensitive EGFR mutations,
a head‐to‐head study was performed to compare chemotherapy and gefitinib in …

The prevalence and mortality rates of cardiovascular diseases are increasing, and new
treatment strategies are urgently needed. From the perspective of basic pathogenesis, the …

Lessons Learned The findings of this prospective, single‐arm, phase II study showed that
neoadjuvant erlotinib was well tolerated and might improve the radical resection rate in …

Introduction There are a number of uncommon EGFR mutations whose associations with
TKIs are not well clarified. Here, we summarize the clinical data of patients with multiple …

The information of the acute oral toxicity for most polycyclic aromatic hydrocarbons (PAHs)
in mammals are lacking due to limited experimental resources, leading to a need to develop …

Background Anlotinib has been demonstrated in clinical trials to be effective in prolonging
the progression-free survival (PFS) and overall survival (OS) of refractory advanced nonsmall …

Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), a member of heterogeneous
nuclear ribonucleoprotein family in actively growing mammalian cells, is involved in a variety of …

This study aimed to compare the differences in characteristics and prognoses between Asian
and white patients receiving immunotherapy for nonsmall cell lung cancer (NSCLC). We …